Is NCT07444216 recruiting in Memphis, TN?

Yes, NCT07444216 is currently recruiting participants at its Memphis, TN location. This cancer, therapy-related clinical trial is actively enrolling qualified participants.

How do I join the cancer, therapy-related clinical trial in Memphis?

To join this clinical trial in Memphis, complete the eligibility form on this page. A study coordinator will contact you to discuss next steps and determine if you qualify.

Is participation in this Memphis clinical trial free?

Yes, all study-related care is provided at no cost to qualified participants. Many studies also offer compensation for time and travel expenses.

Cancer, Therapy-Related Clinical Trial in Memphis, TN

About This Cancer, Therapy-Related Study in Memphis

The purpose of this study is to find better ways to help support families in their hopes during cancer treatment. Primary Objective * To characterize themes related to how patients and parents/caregivers narrate their experience of 'hope' when receiving cancer therapy on a phase 1/2 clinical trial, with a focus on whether, why, when, and how patients' and caregivers' hopes adapt to changing circumstances. * To engage patients, caregivers, and clinicians in focus groups to identify strengths, weaknesses, opportunities, and threats to hope during phase 1/2 clinical trial participation and facilitate the co-design of a stakeholder-driven supportive intervention related to hope based on focus group recommendations. Secondary Objective * To describe health care provider perspectives on patient and family hope and goal-care concordance in the context of phase 1/2 clinical trials.

Sponsor: St. Jude Children's Research Hospital

Who Can Participate

Inclusion Criteria

Patient participants must

Be 12 to 25 years of age. AND

Have a primary cancer diagnosis that is relapsed, refractory, or without curative standard-of-care options as follows:

'Relapsed' disease is defined as disease recurrence following a prior complete or partial response to initial therapy.

'Refractory' disease is defined as failure to achieve remission or response with standard upfront therapy.

Diagnoses will be considered 'without curative standard of care options' if there is no evidence-based curative treatment regimen or where standard therapies offer only palliative or non-curative intent (based on the assessment of the primary attending or division tumor board). AND

Be enrolled OR planning to enroll in a phase 1 or phase 2 trial for cancer-directed therapy.\

Patients will remain eligible until 4 weeks after they begin trial therapy, after which they are no longer eligible unless they subsequently enroll on a different clinical trial. Caregiver participants must

Be a parent or primary caregiver to a child of any age who

Has a primary cancer diagnosis that is relapsed, refractory, or without curative standard-of-care options AND

Is enrolled OR planning to enroll on a phase 1 or phase 2 trial for cancer-directed therapy.\

Parents will remain eligible until 4 weeks after their child begins trial therapy, after which they are no longer eligible unless their child subsequently enrolls on a different clinical trial.

Be ≥ 18 years of age or legally emancipated Medical clinician participants (Primary Objectives 1-2) must

Be a physician, advanced practice provider, or nurse providing direct patient care to the patient participant and/or to the child of the caregiver participant. Psychosocial clinician participants (Primary Objective 2 only) must

Be a psychosocial clinician (e.g., social worker, psychologist, chaplain, child life specialist, music therapist, cultural navigator, etc.) AND

Provide direct or consultative care to pediatric or adolescent/young adult patients with relapsed, refractory, or high-risk cancer and/or their families.

Exclusion Criteria

Patients, Caregivers, and Clinicians will be excluded if they:

Do not meet inclusion criteria.

Decline, refuse, or are unwilling to participate.

Are a minor without a legal guardian available or willing to provide informed consent.

Lack the cognitive, communicative, or physical capacity to meaningfully participate in a photo-narrative interview, as determined by the research team in consultation with the patient, caregiver, and primary oncology team. This includes, but is not limited to, individuals with profound neurocognitive impairment, non-responsiveness, or other conditions that preclude the ability to engage in basic reflection, expression, or shared conversation about images.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Memphis?

Yes, this clinical trial (NCT07444216) has an active research site in Memphis, TN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Cancer, Therapy-Related Treatment Options in Memphis, TN

If you're searching for cancer, therapy-related treatment options in Memphis, TN, this clinical trial (NCT07444216) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Memphis research site is actively enrolling participants for this clinical trial. You'll receive care from experienced cancer, therapy-related specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all cancer, therapy-related clinical trials near you to find additional studies recruiting in your area.

Cancer, Therapy-Related Clinical Trial in Memphis, TN

Expert Care in Memphis

IRB Approved

No-Cost Care

Apply for This Memphis Location

Why Participate?

Simple Process